Purpose 22 We aimed to determine the possible mechanisms of underlying the effects of low 23 dose simvastatin on enhancing the therapeutic efficacy of MSC transplantation in 24 diabetic wound healing. 25 Methods 26 Balb/c nude mice were divided into five groups:-control mice (CON), diabetic 27 mice (DM), diabetic mice pretreated with low-dose simvastatin (DM+SIM), 28 diabetic mice implanted with MSCs (DM+MSCs) and diabetic mice pretreated 29 with low-dose simvastatin and implanted with MSCs (DM+MSCs+SIM). Seven 30 days before wound induction, low dose simvastatin was orally administered to 31 the DM+SIM and DM+MSCs+SIM groups. Eleven weeks after the induction of 32
The diabetic mice were induced by intraperitoneal injection of 145 streptozotocin (STZ; Sigma Chemical Co., USA, 45 mg/kg BW, daily for 5 days). 146 Streptozotocin was freshly dissolved in citrate buffer, pH 4.5 (Sigma Chemical 147 Co., USA). The same volume of citrate buffer, pH 4.5, was injected via the same 148 route into nondiabetic control animals. Glucose levels were measured by a 149 glucometer in tail vein blood samples obtaineds 2 weeks after diabetic induction. 150 Diabetic conditions were defined as a plasma glucose concentration equal to or 151 greater than 200 mg/dL [28] .
152
Cell culture and preparation of mesenchymal stem cells (MSCs) 153 Human bone marrow mesenchymal stem cells were obtained from the 154 Stem Cell and Cell Therapy Research Unit at Chulalongkorn University. Briefly, 155 MSCs were isolated from human bone marrow and were cultured in Dulbecco's 156 modified Eagle's medium (DMEM) containing 5% fetal bovine serum (FBS), 1x 157 penicillin-streptomycin solution, and L-glutamine at 37°C in 5% CO 2 . The 158 medium was exchanged by removing the medium from the flask every 3-days 159 during culture. The phenotypes of the MSCs were positive for CD44, CD73, 160 CD90 and CD105 as shown in Table 1 . Excisional skin wound model 174 In the 11th week after STZ induction, a cutaneous wound was generated. 175 Briefly, after the induction of anesthesia by the intraperitoneal injection of 176 sodium pentobarbital (55 mg/kg), a bilateral full-thickness excisional skin wound 177 0.6x0.6 cm 2 in size was created on both sides of the midline of each mouse [18] . 178 Fibrin gel (Shanghai RAAS-Blood Products Co. Ltd, China) or human 179 mesenchymal stem cells were implanted in the wound bed. The wounds were then 180 covered by square-shaped plastic splints and Tegaderm™ (3M Company, St. 181 Paul, MN, USA) to decrease the possibility of contraction, thus ensuring that 182 closure occurred via re-epithelialization during the wound healing process. 183 Simvastatin supplements at a dosage of 0.25 mg/kg were given daily for 7 days 184 before wound creation and continued to be given until the experimental end-185 point was reached [29] [30] [31] . 
Measurement of neutrophil infiltration 206
Seven and 14 days after wound creation, the mice were sacrificed, and the 207 tissues in the wound areas were harvested. The tissue specimens were fixed in 208 10% formaldehyde for 24 hours. Two-micrometer-thick sections were stained 209 with hematoxylin-eosin (H&E). The number of neutrophils infiltrating in the 210 wound areas was measured using light microscopy (Nikon Eclipse 50i, Nikon, 211 Japan) at 400x magnification and Image-Pro II 6.1 software [34] . These results 212 were confirmed by blind assessment.
213

Determination of tissue VEGF level 214
Seven and 14 days after wound creation, tissue from the wound area was 215 harvested and stored at -80°C for analysis of VEGF using an enzyme-linked 216 immunosorbent assay (murine VEGF-specific ELISA kit (R&D Systems, USA) 217 and a BCA protein assay kit (Thermo scientific, USA)). The amount of VEGF 218 was expressed as picograms per milligram protein unit. To determine MSC migration, the mice were anesthetized with 251 pentobarbital sodium and the jugular vein was cannulated for the injection of The results were expressed as the means ± standard errors of mean (SEM).
260
The differences between groups were determined by one-way analysis of 261 variance (ANOVA), followed by a least significant difference (LSD) post hoc 262 test using SPSS software, version 21. Differences were considered significant at 263 P < 0.05. The increased in the tissue malondialdehyde levels (MDA, an ROS 287 indicator), in the wound area; confirmed that oxidative stress contributed to poor 288 diabetic wound healing (shown in Fig.1A ). The consequent pathogenesis of 289 wounds under diabetes induced oxidative stress, which was confirmed by high 290 numbers of local infiltrating neutrophils, and high IL-6 levels, (Fig.1B, 1C ), could 291 be significantly attenuated by combined simvastatin and MSC treatment, as 292 shown in the DM+MSCs+SIM group, however, our data showed that the effects 293 16 of treatment were significant only in association with decreased anti-oxidant and 294 IL-6 levels, but not in the increased numbers of local infiltrating neutrophils. In 295 the present study, we found that treatments with both MSCs and simvastatin could 296 reduce neutrophils infiltration in wounded diabetic mice on both days 7 and 14.
297
On day 7 after wounding, the decrease in neutrophils infiltration in 298 DM+MSCs+SIM group has showed a greater decrease than that in the 299 DM+MSCs group, but this decrease was not significant. On 14-day after 300 wounding, the results showed significantly decreased neutrophils infiltration in 301 all treated groups, with no significant differences between the DM+MSCs+SIM 302 and DM+MSCs groups. It might have been possible that the levels of neutrophils 303 infiltration were the secondary effects after the anti-inflammatory phase, 304 therefore, they did not reflect the significant improvement of MSC efficacy via 305 the enhancement by simvastatin. As a consequence of the pathogenesis of diabetes-induced oxidative stress, 334 a reduction in the production of vascular endothelial growth factors (VEGF) and 335 delayed wound healing was observed as shown in Fig. 2A . On day 7, VEGF 336 levels were significantly lower in the DM group than in the control group. VEGF 337 levels were significantly higher in the DM+SIM, DM+MSCs, and 338 DM+MSCs+SIM groups than in the DM group (Fig 2A) . However, on day 14, 339 the results showed no significant difference among all groups.
340
The phosphatidylinositol 3-kinases (PI3Ks) and their downstream target 341 AKT are considered crucial signal transduction enzymes that have been 342 investigated extensively for their effects on cell proliferation, and angiogenesis 343 in wound healing. Therefore, we conducted further investigation by using both 344 ELISA and immunohistochemistry techniques to determine the effects of 345 simvastatin on VEGF, pAkt and SDF-1 levels in the wound area (Fig 2A-C) . On 346 day 7 and day 14, pAkt and SDF-1 levels were significantly higher in the 347 DM+MSCs+SIM than that in the DM group.
348
On day 14, a significant decreased %CV was observed in wounds in mice 349 in the DM compared to that in wounds in the control mice group. Interestingly, 350 on the day 14, the %CVs of all treatment-groups, including DM+SIM, 351 DM+MSCs, and DM+MSCs+SIM, were significantly higher than that in the DM 352 group (Fig 2D) . (hMSCs-RFP) was observed by using confocal microscopy, (Fig.3A-D) . In 361 addition, the area of wound neovascularization (expressing green fluorescent 362 FITC (Fig.3E ) was also observed. By using Image Pro II software, the number On days 7 and 14 after wounding, the percentage of wound closure (%WC) 385 was significantly lower in the DM group than in all other groups ( Fig 4A) . The healing involved high numbers of local infiltrating neutrophils, high IL-6 levels, 416 and a reduction in the production of growth factors, such as platelet-derived 417 growth factor (PDGF), transforming growth factor-β (TGF-β) and VEGF [37] [38] .
418
In the present study, we aimed to identify the therapeutic agent that could 419 reduce the effects of contributing factors and improve diabetic wound healing. In implantation significantly higher than that in the group that recieved MSC only.
466
The formation of new blood vessels is considered to be one of the essential 467 physiological processes in wound healing. The new blood vessels will increrase 468 blood circulation and blood supply to the newly formed granulation tissue, and 
